Member Info for BOJO2020

Brazil,

Graeme Dickinson increased his holding by 1%

HSBC went from 0 to 5% holding

On the dates indicated as the resulting position.

ATB

Based only on my own experience (maybe I was unlucky) I can testify that Fidelity are generally NOT co operative and if you need to move your money or trade quickly for any reason they will not be helpful and will likely leave you stranded…You would likely have to sell your stock and end up moving to a better platform.

I have a big holding with Sclp with fidelity and they would not let me sell even a tiny amount on a positive share day! They also take as much as a penny extra for themselves per share each way.

I can say that as a result I have also had to opened an account with interactive and they have been very good in all manner of ways and I would recommend. I don’t know how they compare to other platforms but they are far better than fidelity.

I’ll go for the same as last time as August was always due to be a non event. September should see a more competitive competition IMO.

Congrats to August winners as finding any positives is a job well done. Hope people managed to load up before the market gets up off its backside.

My picks

ANGLE
SCLP
IQAI

Good luck!

Somebody was asking about clinical trials timeframes recently. This interview gives some answers.

https://youtu.be/Y2n7Nh0BBAo

Hi Sunshin,

I have had the same idea for my kid I have bought

10k SCLP @ 14.9p now 21p. Will sell at 35p.

2k Angle @ £1.04 and will sell @ £2.40 or £2.60.

I expect both shares to surpass these selling targets but I want to bank the money. I also picked up Lgen and Aviva a while back.

Basically most biotech and pharmas will swing up and down so good for making money if timing is right.

What do people think is a good price right now for HE1?

Many Thanks

https://twitter.com/i/events/1429801077956702216?s=21

When the leading COVID drug takes nearly 12 months to get approval it certainly puts “our kind of investments,” in perspective…

labs should be MABS **

I think there are a lot of parallels between SAREUM & SCLP. SAR seem to be following the same track but if they don’t have a fund supporting them like Vulpes or Redmile ( as SCLP do), then it will be a long long road. That’s not necessarily a negative as it means the share price is still affordable. Also there is no reason why such a fund will not jump on board in the future so definitely a hold imo. Also they have novel drugs and labs are certainly the right area. Again just look at any MABS and see how long they take to make it to market. Long road but when they are approved the gains would be mind blowing.

If you believe n the science now would be the time to load up.

AIMO

Sorry Tro

Can’t make head nor tail of that post. Have you invested in Valletta or Adriatic?

MJ, I agree.

This is a shop window for COVIDITY which will showcase Sclp platforms; avidimab, scib and moditope. Each one of these platforms has serious potential to be used in conjunction with other therapeutics and possibly vax. The commercial opportunities are unlikely to be in the vaccine but the platforms that enhance immune response. Remember the scientists are interested in how it works as much as does it work. That is how novel therapies are found.

It is also worth considering that with the SP circa 21p will grow based on this exercise. I don’t think the company is looking for a big tick and validation by EMA or FDA etc. What SCLP are doing is not unlike Sareum. They are just more developed. Showcasing platforms so they can be used as part of a ****tail of therapies is becoming increasingly common and Sclp are not far behind biotech in that regard.

I agree that getting any drug, vax, therapeutic to market is unlikely but the money and share price appreciation is in the detail!

Scancell have employed pharmjet system to administer needle free injections of the COVIDITY vaccine. The video below demonstrates the principle and is very interesting. These kids don’t flinch or even cry!

https://youtu.be/OA_M3Bkhp0g

Video curtesy of Bermuda Shorts.

Also worth pointing out first injection must be imminent as they have announced delivery method and been given clearance for the trial.

ATB

Brazil

For NEXT SOURCE on the TSX (Canada) market I have signed up for email notifications direct from the company and they arrive in good time. Also get better and more useful information TBH. I don’t have many foreign stocks to be honest.

The book build / fundraise was for institutions and I seem to remember mention of US investors. Can’t see them selling out @ £1.17p. It is an orderly way to allow that type of investor on board IMO. For them it would be just the beginning…

Also I can second excellent post from SK on the other channel with equally good replies.

Good Luck

https://www.lse.co.uk/rns/SCLP/scancell-selects-pharmajet8217s-needle-free-systems-si55pofvwqgchvf.html

One would think TB would see some future value in his “investment”. On the other hand he would only need to see a few pence to make a lot of money.

Dibs I have doubled my original target holding here as it eases the burden in the share price performance. Whilst I hope to see £1.40 then £2 incoming fairly soon, my original dreamy SP target of £15 is now halved. Who knows what the eventual share price might be but even something in the order of double or treble £1.04 (last week) would provide an excellent return. Anyway that’s how I am playing it but each to their own. I can’t draw my pension for a while yet so Angle have plenty of time to blossom.

Good Luck

Yes those cheap prices have allowed me to surpass my target and keep a very reasonable average. I am a very happy bunny right now. There will always be opportunities to top up as this has such a long way to go IMO.

** sorry should say I will hold. Each to their own of course.

Yes a nice upward trend atm. May it even hit previous highs which would represent a 35% profit? I think the only sellers now will be private investors and maybe a fund or institution that have their own separate reasons and other pressures. Maybe a month or so till FDA decision but this is a world way from how IMM (he shudders!) handled FDA. We shall hold now unless it looks over bought and then I’ll trade a few.

GLA